Insider and congress filings
Elevance Health Inc. (ELV)
About Elevance Health Inc.
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Chief executive
- Gail Koziara Boudreaux
- Employees
- 96,615
- Listed since
- Oct 30, 2001
- Market value
- $86.1B
- Price to earnings
- 17.6
- Earnings per share
- $22.78
- Dividend yield
- 1.73%
Earnings
6 reported quarters · next on Oct 21, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 15, 2026 | $7.45 | $6.21 | $49.8B | $48.9B | EPS beatRevenue beat |
| Q1 FY2026reported Apr 22, 2026 | $12.58 | $10.82 | $49.5B | $48.2B | EPS beatRevenue beat |
| Q4 FY2025reported Jan 28, 2026 | $3.33 | $3.10 | $49.3B | $49.8B | EPS beatRevenue in line |
| Q3 FY2025reported Oct 21, 2025 | $6.03 | $4.93 | $50.1B | $49.4B | EPS beatRevenue in line |
| Q2 FY2025reported Jul 17, 2025 | $8.84 | $8.91 | $49.4B | $48.2B | EPS in lineRevenue beat |
| Q1 FY2025reported Apr 22, 2025 | $11.97 | $11.41 | $48.8B | $46.3B | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $7.3B | 18,991,090 | -4.5% | 8.72% |
| Vanguard Capital Management LLC | $5.4B | 14,058,204 | -2.0% | 6.45% |
| State Street Corp | $4.0B | 10,426,610 | +1.3% | 4.79% |
| Wellington Management Group LLP | $3.6B | 9,213,513 | +12.0% | 4.23% |
| Vanguard Portfolio Management LLC | $2.4B | 6,214,356 | -2.2% | 2.85% |
| Sanders Capital, LLC | $2.3B | 5,825,024 | -1.2% | 2.67% |
| Geode Capital Management, LLC | $2.0B | 5,166,124 | -0.5% | 2.37% |
| Harris Associates L P | $1.9B | 4,924,511 | +2.7% | 2.26% |
| Artisan Partners Limited Partnership | $1.8B | 4,581,222 | -10.6% | 2.10% |
| Invesco Ltd. | $1.6B | 4,234,231 | -12.1% | 1.94% |
| First Eagle Investment Management, LLC | $1.6B | 4,188,196 | +1.4% | 1.92% |
| Price T Rowe Associates Inc | $1.6B | 4,014,991 | -15.4% | 1.84% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
10 filings of 367 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| Ramiro G. PeruDirector | Bought | 1,000 | $366.05 | $366K | Jul 17, 2026 | 0d |
| Gail BoudreauxPresident and CEO | Bought · 2 lines | 2,725 | $367.79 | $1.0M | Jul 17, 2026 | 0d |
| Ronald W. PenczekCAO & Controller | Sold | 369 | $403.16 | $149K | Jun 12, 2026 | 3d |
| Robert L. Dixon Jr.Director | Sold | 151 | $401.77 | $61K | Jun 11, 2026 | 1d |
| Ronald W. PenczekCAO & Controller | Sold | 1,531 | $403.13 | $617K | May 19, 2026 | 1d |
| Amy W. SchulmanDirector | Sold | 26 | $287.50 | $7K | Mar 12, 2026 | 11d |
| Charles Morgan Kendrick Jr.EVP & President, Commercial | Sold | 3,196 | $284.92 | $911K | Mar 6, 2026 | 3d |
| Steven H. CollisDirector | Bought | 3,000 | $289.84 | $870K | Mar 5, 2026 | 1d |
| Susan D. DeVoreDirector | Bought | 1,200 | $312.15 | $375K | Aug 19, 2025 | 2d |
| Gail BoudreauxPresident and CEO | Bought | 5,116 | $287.12 | $1.5M | Jul 18, 2025 | 0d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in ELV
20 disclosures of 88 on record · median 28d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +3.8%S&P +2.7% · vs S&P 500 +1.1% | Jul 20, 2026 | Aug 7, 2026 | 18d |
| Alan ArmstrongSelfFiled late | Stock | Purchase | $1,001 - $15,000 | +38.6%S&P +20.2% · vs S&P 500 +18.4% | Mar 27, 2026 | Jul 21, 2026 | 116d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +1.1%S&P +3.2% · vs S&P 500 -2.1% | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +28.9%S&P +12.3% · vs S&P 500 +16.7% | Apr 13, 2026 | May 11, 2026 | 28d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +39.4%S&P +20.7% · vs S&P 500 +18.7% | Mar 30, 2026 | Apr 7, 2026 | 8d |
| Ro Khanna | Stock | Purchase | $15,001 - $50,000 | +21.3%S&P +10.9% · vs S&P 500 +10.5% | Feb 24, 2026 | Mar 9, 2026 | 13d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +15.1%S&P +11.6% · vs S&P 500 +3.5% | Feb 17, 2026 | Mar 9, 2026 | 20d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +17.4%S&P +10.9% · vs S&P 500 +6.5% | Jan 29, 2026 | Feb 6, 2026 | 8d |
| Markwayne MullinJoint | Stock | Purchase | $15,001 - $50,000 | +14.3%S&P +11.0% · vs S&P 500 +3.3% | Dec 29, 2025 | Jan 16, 2026 | 18d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +26.7%S&P +11.6% · vs S&P 500 +15.2% | Nov 3, 2025 | Dec 8, 2025 | 35d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | +16.3%S&P +11.4% · vs S&P 500 +4.8% | Oct 27, 2025 | Nov 10, 2025 | 14d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +26.6%S&P +17.8% · vs S&P 500 +8.8% | Sep 5, 2025 | Oct 3, 2025 | 28d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +24.2%S&P +14.9% · vs S&P 500 +9.3% | Sep 29, 2025 | Oct 3, 2025 | 4d |
| Michael T. McCaulFiled late | Fund | Exchange | $100,001 - $250,000 | -22.0%S&P +46.9% · vs S&P 500 -68.9% | Mar 25, 2024 | Sep 25, 2025 | 549d |
| Val T. HoyleSpouseFiled late | Stock | Sale | $1,001 - $15,000 | +0.1%S&P +31.1% · vs S&P 500 -31.0% | Jan 13, 2025 | Sep 12, 2025 | 242d |
| Val T. HoyleSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | -3.3%S&P +31.1% · vs S&P 500 -34.4% | Oct 29, 2024 | Sep 12, 2025 | 318d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +43.6%S&P +21.4% · vs S&P 500 +22.2% | Aug 5, 2025 | Sep 12, 2025 | 38d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +35.2%S&P +18.4% · vs S&P 500 +16.8% | Aug 13, 2025 | Sep 12, 2025 | 30d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | +28.6%S&P +20.2% · vs S&P 500 +8.5% | Aug 21, 2025 | Sep 11, 2025 | 21d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +44.4%S&P +20.8% · vs S&P 500 +23.6% | Aug 4, 2025 | Sep 9, 2025 | 36d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
6 members · estimate, as of Sep 10, 20266 members report a position (estimated). The largest estimated position is in the $50,001 - $100,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Sheldon Whitehouse | Democrat · Senate | $50,001 - $100,000 | 0.3% |
| Markwayne Mullin | Republican · Senate | $50,001 - $100,000 | 0.3% |
| Robert J. Wittman | Republican · House | $15,001 - $50,000 | 3.9% |
| Dan Newhouse | Republican · House | $1,001 - $15,000 | 1.4% |
| Gilbert Ray Cisneros, Jr. | Democrat · House | $1,001 - $15,000 | <0.1% |
| Robert Bresnahan | Republican · House | $1,001 - $15,000 | 0.1% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Awards, option exercises and gifts (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Ryan R. CraigEVP & Chief HR Officer | Tax withholding | 144 | Sep 2, 2026 |
| Erin M. WesslingEVP & Chief Legal Officer | Tax withholding | 94 | Sep 2, 2026 |
| Erin M. WesslingEVP & Chief Legal Officer | Tax withholding | 255 | Sep 3, 2026 |
| Ronald W. PenczekCAO & Controller | Option exercise | 1,531 | May 19, 2026 |
| Susan D. DeVoreDirector | Stock award | 563 | May 13, 2026 |
| Lewis Hay IIIDirector | Stock award | 563 | May 13, 2026 |
| Bahija JallalDirector | Stock award | 563 | May 13, 2026 |
| Antonio F. NeriDirector | Stock award | 563 | May 13, 2026 |
| Ramiro G. PeruDirector | Stock award | 563 | May 13, 2026 |
| Ryan M. SchneiderDirector | Stock award | 563 | May 13, 2026 |
| Amy W. SchulmanDirector | Stock award | 563 | May 13, 2026 |
| Deanna D. Strable-SoethoutDirector | Stock award | 563 | May 13, 2026 |
| Robert L. Dixon Jr.Director | Stock award | 563 | May 13, 2026 |
| Steven H. CollisDirector | Stock award | 563 | May 13, 2026 |
| Ronald W. PenczekCAO & Controller | Stock award | 4,070 | Mar 2, 2026 |
| Gail BoudreauxPresident and CEO | Stock award | 90,498 | Mar 2, 2026 |
| Gail BoudreauxPresident and CEO | Tax withholding | 6,713 | Mar 2, 2026 |
| Gail BoudreauxPresident and CEO | Tax withholding | 1,736 | Mar 3, 2026 |
| Mark KayeEVP & CFO | Tax withholding | 271 | Mar 2, 2026 |
| Mark KayeEVP & CFO | Stock award | 41,767 | Mar 2, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling ELV?
Across the 10 most recent open-market filings shown here, 5 were purchases and 5 were sales.
Which members of Congress have traded ELV?
Ro Khanna, Alan Armstrong, Markwayne Mullin, Michael T. McCaul, Val T. Hoyle, Gilbert Ray Cisneros, Jr. and others disclosed ELV transactions in the filings shown here.
Which members of Congress hold ELV?
6 members of Congress report a position in ELV in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to Sheldon Whitehouse, Markwayne Mullin and Robert J. Wittman. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is ELV in the S&P 500 or the Nasdaq 100?
Elevance Health Inc. is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.
How quickly are ELV trades disclosed?
Insider filings on this page reached the public a median of 1 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 28 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.